Your browser doesn't support javascript.
loading
Survival and prognostic factors for patients with melanoma brain metastases in the era of modern systemic therapy.
Tio, Martin; Wang, Xuan; Carlino, Matteo S; Shivalingam, Brindha; Fogarty, Gerald B; Guminski, Alexander D; Lo, Serigne; Hong, Angela M; Menzies, Alexander M; Long, Georgina V.
Afiliación
  • Tio M; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW, Australia.
  • Wang X; Peking University Cancer Hospital and Institute, Beijing, China.
  • Carlino MS; Melanoma Institute Australia, North Sydney, NSW, Australia.
  • Shivalingam B; Crown Princess Mary Cancer Centre Westmead, Sydney, NSW, Australia.
  • Fogarty GB; Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia.
  • Guminski AD; Melanoma Institute Australia, North Sydney, NSW, Australia.
  • Lo S; Sydney Medical School, The University of Sydney, Camperdown, NSW, Australia.
  • Hong AM; Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  • Menzies AM; Mater Hospital, North Sydney, NSW, Australia.
  • Long GV; Melanoma Institute Australia, North Sydney, NSW, Australia.
Pigment Cell Melanoma Res ; 31(4): 509-515, 2018 07.
Article en En | MEDLINE | ID: mdl-29277979

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Melanoma Tipo de estudio: Prognostic_studies Idioma: En Revista: Pigment Cell Melanoma Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Melanoma Tipo de estudio: Prognostic_studies Idioma: En Revista: Pigment Cell Melanoma Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article